Shares of Critical Metals Corp are up another 7% today, extending their total rebound to more than 80%. The main driver behind the move is the renewed focus on US interest in Greenland.
Critical Metals is highly dependent on developments in the relationship between Greenland and the United States, as its key asset is the Tanbreez rare-earth metals project located in Greenland. This means that permits, export rights and the project’s long-term viability remain under the authority of Greenlandic and Danish regulators, while potential customers, financing partners and strategic backing are expected to come largely from the United States.
At present, the company’s valuation is largely driven by how the Greenland–US relationship evolves. Closer strategic cooperation could unlock financing and demand, while diplomatic tension or political uncertainty could delay project development and increase risk.
The White House has said that President Donald Trump is considering “a broad range of options” regarding the acquisition of Greenland — including the potential use of US military forces — describing the Arctic island as a national-security priority. European leaders issued a coordinated response expressing support for Denmark and Greenland, emphasizing sovereignty and territorial integrity under international law, while NATO partners warned that any US military action could destabilize the alliance.
From a strategic perspective, Critical Metals is positioning itself as a Western supplier of critical raw materials within a growing portfolio of projects. Tanbreez is regarded as one of the largest rare-earth deposits in the world.
The latest gains are the result of renewed speculation around possible US involvement in resource extraction in Greenland — a pattern similar to what was seen at the turn of September and October last year.
Micron Bets Billions on AI. Hereโs Whatโs Driving the New Semiconductor Supercycle! ๐
Will the defense sector keep European stock markets afloatโ
Nvidia and China: Huge Money and Growth Potential!๐
Euphoria in U.S. defense stocks ๐ฝ An additional $500B for Department of War?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
